Ceftazidime (SXP)

What it is used for

Treatment of single and mixed infections caused by susceptible aerobic organisms with suspected or documented resistance to other antimicrobials, but not to ceftazidime; as an alternative to aminoglycosides in pseudomonal infection in patients in whom aminoglycoside toxicity is a cause for concern and other antipseudomonal antibiotics cannot be used. Indications include the following. Severe infections in general. For example: septicaemia (including neonatal sepsis), bacteraemia; in patients in intensive care units with specific problems, e.g. infected burns. Respiratory tract. eg: pneumonia, bronchopneumonia, infected pleurisy, infected bronchiectasis and bronchitis. Severe ear, nose and throat infections. For example: otitis media, mastoiditis. Urinary tract. For example: acute and chronic pyelonephritis, pyelitis, cystitis, urethritis (bacterial only); infections associated with bladder and renal stones. Skin and soft tissue. For example: erysipelas, abscesses, cellulitis, infected burns and wounds, mastitis. Gastrointestinal and abdominal. For example: intra-abdominal abscesses, enterocolitis. Bone and joint. For example: osteitis, osteomyelitis, septic arthritis, infected bursitis.